Tarcine BioMed attended the 67th American Association for Clinical Chemistry (AACC) Annual meeting & Clinical Lab Expo, the world’s largest show for Clinical Chemistry in Atlanta, Georgia during July 28th – 30th, 2015. More than 700 exhibitors filled the show floor of Atlanta’s convention center, with displays of the latest diagnostic technologies, including but not limited to mobile health, molecular diagnostics, mass spectrometry, point-of-care, and automation. According to AACC press release, more than 18,000 laboratory medicine professionals had attended the 2015 AACC Annual Meeting & Clinical Lab Expo. It is the third time that Tarcine BioMed has been an honored exhibitor at AACC Expo.
Tarcine products in early screening of cancer, myocardial infarction warning, and infectious disease testing are Chinese FDA approved. The lead product NPCheckTM, the only test kit approved by Chinese FDA for adjuvant diagnostic and clinical management of Nasopharyngeal Carcinoma, is also CE marked.
Tarcine had this opportunity to showcase products to customers, and distributors from various countries. Tarcine also engaged and built relationship with, through leaders in the health care profession in our efforts to continuously improve our products and services.